Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy

被引：0
|
作者：
D. Gibellini
M. Borderi
E. Vanino
A. Clò
S. Morini
L. Calza
M. C. Re
Pl. Viale
机构：
[1] University of Bologna,Department of Haematology and Oncological Sciences, Microbiology Section
[2] University of Bologna,Department of Internal Medicine, Aging and Nephrology, Infectious Diseases Section
来源：
Clinical Reviews in Bone and Mineral Metabolism | 2012年 / 10卷 / 4期
关键词：
HIV; Bone; Osteopenia/osteoporosis; Virus; Antiretrovirals;
D O I：
10.1007/s12018-012-9133-y
中图分类号：
学科分类号：
摘要：
In addition to immune system, HIV infection can determine the onset of functional dysfunctions of several organs and tissues such as central nervous system, cardiovascular system, kidney, and bone. It is noteworthy that HIV-infected individuals show an increased risk of bone mass loss with subsequent osteopenia and osteoporosis development. Interestingly, antiretroviral therapy is not able to tackle the bone derangement but, on the contrary, it can induce a progressive bone mass loss, especially when specific antiretroviral drugs are used. In this report, we summarized the HIV and antiretroviral-related mechanisms involved in the osteopenia and osteoporosis induction.
引用
收藏
页码：236 / 245
页数：9
相关论文
共 50 条
  • [31] Antiretroviral therapy for hepatitis B virus - HIV - Coinfected patients: Promises and pitfalls
    Levy, Vivian
    Grant, Robert M.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 904 - 910
  • [32] HIV infection and antiretroviral therapy: Effect on hepatitis C virus quasispecies variability
    Shuhart, MC
    Sullivan, DG
    Bekele, K
    Harrington, RD
    Kitahata, MM
    Mathisen, TL
    Thomassen, LV
    Emerson, SS
    Gretch, DR
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (09): : 1211 - 1218
  • [33] Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapy
    Lafeuillade, A
    Poggi, C
    Pellegrino, P
    Profizi, N
    INFECTION, 1996, 24 (06) : 412 - 418
  • [34] Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related
    Falasca, Katia
    Reale, Marcella
    Ucciferri, Claudio
    Di Nicola, Marta
    Di Martino, Giuseppe
    D'Angelo, Chiara
    Coladonato, Simona
    Vecchiet, Jacopo
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (03) : 246 - 253
  • [35] Modeling the role of acquired immune response and antiretroviral therapy in the dynamics of HIV infection
    Dubey, Preeti
    Dubey, Uma S.
    Dubey, Balram
    MATHEMATICS AND COMPUTERS IN SIMULATION, 2018, 144 : 120 - 137
  • [36] Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation
    Grulich, Andrew E.
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) : 183 - 187
  • [37] The role of children in their HIV-positive parents' management of antiretroviral therapy in Uganda
    Nalugya, Ruth
    Russell, Steven
    Zalwango, Flavia
    Seeley, Janet
    AJAR-AFRICAN JOURNAL OF AIDS RESEARCH, 2018, 17 (01): : 37 - 46
  • [38] Risk factors of osteopenia in HIV-infected women: No role of antiretroviral therapy
    Libois, A.
    Clumeck, N.
    Kabeya, K.
    Gerard, M.
    De Wit, S.
    Poll, B.
    Tondeur, M.
    Rozenberg, Serge
    MATURITAS, 2010, 65 (01) : 51 - 54
  • [39] Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV - The role of hepatitis B and C virus infection
    Aceti, A
    Pasquazzi, C
    Zechini, B
    De Bac, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01) : 41 - 48
  • [40] Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
    Hsue, Priscilla Y.
    Hunt, Peter W.
    Schnell, Amanda
    Kalapus, S. Craig
    Hoh, Rebecca
    Ganz, Peter
    Martin, Jeffrey N.
    Deeks, Steven G.
    AIDS, 2009, 23 (09) : 1059 - 1067
12345